Netherlands· NL-5dcfb2be5923
Luxturna 5 x 10^12 vectorgenomen/ml concentraat en oplosmiddel voor oplossing voor injectie
A voretigene neparvovec product containing voretigeen neparvovec, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Voretigene neparvovec is registered in 13 of 19 countries.
Countries holding a registration under ATC S01XA27 (voretigene neparvovec), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Voretigene neparvovec · ATC S01XA27
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- VORETIGEEN NEPARVOVEC
- Manufacturer
- Novartis Europharm Limited
- Country
- Netherlands (NL)
- ATC code
- S01XA27
- ATC class
- Voretigene neparvovec
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/18/1331
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Voretigene neparvovec in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumLuxturna 5 10*12 vg/mlNovartis Europharm
- CanadaLUXTURNANOVARTIS PHARMACEUTICALS CANADA INC
- SwitzerlandLuxturna 5 x 10e12, Konzentrat und Lösungsmittel zur Herstellung einer InjektionslösungNovartis Pharma Schweiz AG
- CzechiaLUXTURNANovartis Europharm Limited, Dublin
- SpainLUXTURNA 5 x 10¹² GENOMAS VECTORIALES/ML CONCENTRADO Y DISOLVENTE PARA SOLUCION INYECTABLENovartis Europharm Limited
- FinlandLuxturnaNovartis Europharm Limited
- FranceLUXTURNA 5 x 1 000 000 000 000 génomes de vecteur/mL, solution à diluer et solvant pour solution injectableNOVARTIS EUROPHARM (IRLANDE)
- United KingdomLuxturna 5 tera vector genomes/1ml concentrate and solvent for solution for injection vialsNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Luxturna
- Liechtenstein · Luxturna
- Norway · Luxturna
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbb8175d-123f-4e94-ae07-89d0f4fc3147 GET /v1/drugs/bbb8175d-123f-4e94-ae07-89d0f4fc3147?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat en oplosmiddel voor suspensie voor injectie",
"route": "Oculair gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/luxturna-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Voretigene neparvovec",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp121774",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
"DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
"NATRIUMCHLORIDE",
"NATRIUMCHLORIDE",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"POLOXAMEER 188",
"POLOXAMEER 188",
"WATER VOOR INJECTIE",
"WATER VOOR INJECTIE"
],
"substances": [
"VORETIGEEN NEPARVOVEC"
],
"leaflet_url": null,
"authorised_at": "2018/11/22",
"procedure_number": "EMEA/H/C/004451",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/18/1331",
"additional_monitoring": "Y"
}See everything about voretigene neparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.